Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/16781372

J. Am. Coll. Cardiol. 2006 Jun 20 47 12 2444-55

Download in:

View as

General Info

PMID
16781372